Research Consent Forms
The Center for Clinical Pharmacology has the current research studies available:
Center for Clinical Pharmacology Research Data Registry
Screening for Drug Metabolism Enzyme Studies
Is There Selective Regulation of Individual CYP Enzymes in Studies with Paroxetine, Disulfiram and Rifampin
CENTER FOR CLINICAL PHARMACOLOGY RESEARCH DATA REGISTRY
The purpose of the Center for Clinical Pharmacology Research Data Registry is to identify individuals who are willing to be contacted to participate in research studies that are being conducted in clinical pharmacology. This registry will allow us to gather basic personal demographic information to be used in re-contacting subjects for future studies. This personal information will be stored in a secure location.
Click here to view the Registry Protocol
SCREENING FOR DRUG METABOLISM ENZYME STUDIES
You are being asked to provide your consent to be screened for future participation in research studies to investigate subject’s ability to eliminate drugs that are metabolized (break down) by the liver. This screening study includes a physical examination, medical history and urine and blood samples. The results of these tests will determine your eligibility for future research studies.
Click here to view the Screening Protocol
IS THERE SELECTIVE REGULATION OF INDIVIDUAL CYP ENZYMES IN STUDIES WITH PAROXETINE, DISULFIRAM AND RIFAMPIN?
The purpose of this study is to determine how one drug can influence the metabolism (breakdown) of another drug and learn more information about the mechanisms involved in drug interactions. The drug interactions we are investigating will be assessed by blood and urinary measures of drugs and their metabolites (break down products).
Click here to view the Paroxetine, Disulfiram, Rifampin Protocol
CONTACT INFORMATION:
Yvonne Cannon, RN, CCRC
104 Lothrop Street
#116 Lothrop Hall
Pittsburgh, PA 15213
Phone: 412-648-2288
Fax: 412-648-7107
|
